2023Q1营收归零,继续亏损,目前看不到投资价值。查看全文
美股律师郝俊波2021-06-09 17:18
$AcelRx制药(ACRX)$ 【AcelRx Pharmaceuticals Inc(ACRX)证券诉讼信息 】
AcelRx Pharmaceuticals Inc(ACRX)因证券欺诈案已经于近日被投资者诉至法院。在目前的诉讼中投资者指控该公司在2020年3月17日至2021年2月12日期间就公司的业务、运营及合规问题进行虚假陈述,未向投资者披露以下重大不...查看全文
$AcelRx Pharmaceuticals (ACRX)$ 8-K - Current report Filed: 2016-09-19 AccNo: 0001437749-16-038840 Size: 115 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$AcelRx Pharmaceuticals (ACRX)$ 内部交易: 2016-09-15,10% Owner,PERCEPTIVE ADVISORS LLC ,卖出,392850普通股, $3.70
$AcelRx Pharmaceuticals (ACRX)$ 8-K - Current report Filed: 2016-09-15 AccNo: 0001437749-16-038720 Size: 66 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$AcelRx Pharmaceuticals (ACRX)$ 8-K - Current report Filed: 2016-08-15 AccNo: 0001437749-16-037360 Size: 2 MBItem 7.01: Regulation FD DisclosureItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$AcelRx Pharmaceuticals (ACRX)$ 8-K - Current report Filed: 2016-08-02 AccNo: 0001437749-16-036143 Size: 111 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$AcelRx Pharmaceuticals (ACRX)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2016-07-29 AccNo: 0001437749-16-035895 Size: 5 MB 网页链接
$AcelRx Pharmaceuticals (ACRX)$ 8-K - Current report Filed: 2016-07-08 AccNo: 0001437749-16-035024 Size: 5 MBItem 7.01: Regulation FD DisclosureItem 9.01: Financial Statements and Exhibits 网页链接
$AcelRx Pharmaceuticals (ACRX)$ 8-K - Current report Filed: 2016-06-22 AccNo: 0001437749-16-034251 Size: 36 KBItem 5.07: Submission of Matters to a Vote of Security Holders 网页链接
$AcelRx Pharmaceuticals (ACRX)$ 424B5 - Prospectus [Rule 424(b)(5)] Filed: 2016-06-21 AccNo: 0001437749-16-034184 Size: 427 KB 网页链接
$AcelRx Pharmaceuticals (ACRX)$ 8-K - Current report Filed: 2016-06-21 AccNo: 0001437749-16-034183 Size: 326 KBItem 1.01: Entry into a Material Definitive AgreementItem 9.01: Financial Statements and Exhibits 网页链接